191 related articles for article (PubMed ID: 21417872)
1. Newer antifungal agents.
Türel O
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):325-38. PubMed ID: 21417872
[TBL] [Abstract][Full Text] [Related]
2. New and emerging treatments for fungal infections.
Pasqualotto AC; Denning DW
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i19-30. PubMed ID: 18063600
[TBL] [Abstract][Full Text] [Related]
3. Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Aperis G; Mylonakis E
Expert Opin Investig Drugs; 2006 Jun; 15(6):579-602. PubMed ID: 16732713
[TBL] [Abstract][Full Text] [Related]
4. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Rybak JM; Marx KR; Nishimoto AT; Rogers PD
Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
[TBL] [Abstract][Full Text] [Related]
5. Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.
Guinea J; Bouza E
Future Microbiol; 2008 Dec; 3(6):603-15. PubMed ID: 19072177
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections.
Livermore J; Hope W
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):759-65. PubMed ID: 22530880
[TBL] [Abstract][Full Text] [Related]
7. Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Pasqualotto AC; Thiele KO; Goldani LZ
Curr Opin Investig Drugs; 2010 Feb; 11(2):165-74. PubMed ID: 20112166
[TBL] [Abstract][Full Text] [Related]
8. Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
Pettit NN; Carver PL
Ann Pharmacother; 2015 Jul; 49(7):825-42. PubMed ID: 25940222
[TBL] [Abstract][Full Text] [Related]
9. [Antifungal therapy update: new drugs and medical uses].
Fortún J
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():38-44. PubMed ID: 22305668
[TBL] [Abstract][Full Text] [Related]
10. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Ledoux MP; Denis J; Nivoix Y; Herbrecht R
J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi.
Desai A; Kovanda L; Kowalski D; Lu Q; Townsend R; Bonate PL
Antimicrob Agents Chemother; 2016 Sep; 60(9):5483-91. PubMed ID: 27381396
[TBL] [Abstract][Full Text] [Related]
12. Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
Odds FC
Curr Opin Investig Drugs; 2006 Aug; 7(8):766-72. PubMed ID: 16955689
[TBL] [Abstract][Full Text] [Related]
13. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Miceli MH; Kauffman CA
Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
[TBL] [Abstract][Full Text] [Related]
14. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
Thompson GR; Wiederhold NP
Mycopathologia; 2010 Nov; 170(5):291-313. PubMed ID: 20524153
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
McCarthy MW; Moriyama B; Petraitiene R; Walsh TJ; Petraitis V
Clin Pharmacokinet; 2018 Dec; 57(12):1483-1491. PubMed ID: 29725999
[TBL] [Abstract][Full Text] [Related]
16. Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.
Kovanda LL; Maher R; Hope WW
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):887-97. PubMed ID: 27160418
[TBL] [Abstract][Full Text] [Related]
17. Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study).
Kovanda LL; Desai AV; Lu Q; Townsend RW; Akhtar S; Bonate P; Hope WW
Antimicrob Agents Chemother; 2016 Aug; 60(8):4568-76. PubMed ID: 27185799
[TBL] [Abstract][Full Text] [Related]
18. Micafungin use in children.
Emiroglu M
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
[TBL] [Abstract][Full Text] [Related]
19. [Current therapeutic options in invasive mycosis and potential therapeutic role of isavuconazole].
Garcia-Vidal C
Rev Iberoam Micol; 2018; 35(4):192-197. PubMed ID: 30455108
[TBL] [Abstract][Full Text] [Related]
20. Isavuconazole: Case Report and Pharmacokinetic Considerations.
Marchesi F; Girmenia C; Goffredo BM; Salvatorelli E; Romano A; Mengarelli A; Minotti G; Menna P
Chemotherapy; 2018; 63(5):253-256. PubMed ID: 30458443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
